發(fā)布時(shí)間：2018-06-25 02:52

  本文選題：兔VX2肢體軟組織腫瘤模型 + 容積弧形調(diào)強(qiáng)放療��； 參考：《新疆醫(yī)科大學(xué)》2015年博士論文

【摘要】：目的:1)通過(guò)超聲引導(dǎo)建立兔VX2肢體軟組織腫瘤模型,為后期的干預(yù)研究和影像學(xué)評(píng)價(jià)奠定基礎(chǔ);2)在腫瘤模型上實(shí)施新輔助放療,應(yīng)用容積弧形調(diào)強(qiáng)放療-同步推量(VMAT-SIB)技術(shù)在腫瘤毗鄰骨骼的區(qū)域提高照射劑量,局部產(chǎn)生放射性損傷,制作一個(gè)壞死帶定義為外科邊界,評(píng)價(jià)制作外科邊界的可行性、有效性;3)在腫瘤模型上,實(shí)施大分割放療制作外科邊界,評(píng)價(jià)其安全性。方法:1)選用雄性新西蘭兔30只,隨機(jī)分為對(duì)照組6只(在超聲引導(dǎo)下注射生理鹽水0.5ml),模型組24只(在超聲引導(dǎo)下注射腫瘤組織混懸液0.5ml)。兩組應(yīng)用磁共振彌散成像(MRDWI)和三維超聲觀察腫瘤的形態(tài)、信號(hào)特點(diǎn)及體積變化。對(duì)照組在采集完影像后處死動(dòng)物觀察組織學(xué)變化。模型組于第14天、21天、28天隨機(jī)分批處死6只動(dòng)物觀察組織學(xué)變化。剩下6只動(dòng)物不處死,觀察帶瘤生存時(shí)間;2)選用30只腫瘤模型兔,隨機(jī)分為對(duì)照組:10只;調(diào)強(qiáng)放療(IMRT)組:10只;VMAT-SIB組:10只。三組在放療后一周進(jìn)行影像學(xué)采集:MRDWI、三維能量多普勒超聲血管成像(3D-PDA)。之后,處死動(dòng)物,觀察組織學(xué)變化以及采用免疫組化檢查腫瘤組織的增殖、凋亡、血管密變化;3)選用40只腫瘤模型兔,隨機(jī)分為對(duì)照組:10只;VMAT-SIB3Gy組:10只;VMAT-SIB4Gy組:10只;VMAT-SIB5Gy組:10只。四組在放療后,參照CTCAE分級(jí)觀察皮膚的大體情況。采用HE染色觀察皮膚和骨組織的形態(tài)學(xué)改變。采用透射電鏡觀察骨細(xì)胞超微結(jié)構(gòu)改變。采用熒光原位雜交(FISH)測(cè)定皮膚組織PDGF-B、EGF的表達(dá)情況。采用實(shí)時(shí)熒光定量PCR測(cè)定皮膚組織VEGF、bFGF的基因表達(dá)量。結(jié)果:1)三維超聲和MRDWI證實(shí),24只實(shí)驗(yàn)動(dòng)物的種植成瘤率達(dá)100%,24只腫瘤模型兔全部存活。三維超聲結(jié)果,對(duì)照組在注射部位未見(jiàn)異常改變。模型組隨著時(shí)間的增加腫瘤體積逐漸增大,與對(duì)照組比較其差異具有統(tǒng)計(jì)學(xué)意義(P0.05)。MRDWI顯示:對(duì)照組未見(jiàn)明顯的異常信號(hào)。模型組在左側(cè)后肢可見(jiàn)腫瘤影像,腫瘤組織在DWI圖呈高信號(hào);在ADC圖呈低信號(hào)。組織學(xué)結(jié)果,對(duì)照組:HE可見(jiàn)正常的橫紋肌及支氣管肺泡組織。模型組:第14天取材,HE可見(jiàn)生長(zhǎng)旺盛的瘤細(xì)胞呈不規(guī)則致密排列,侵犯橫紋肌。第21天取材,HE可見(jiàn)腫瘤區(qū)與片狀壞死區(qū)邊界不清,腫瘤生長(zhǎng)區(qū)內(nèi)細(xì)胞較密集。第28天取材,HE可見(jiàn)部分的腫瘤細(xì)胞核固縮、細(xì)胞核碎裂。第60天取材,HE可見(jiàn)腫瘤邊緣仍有腫瘤細(xì)胞,腫瘤實(shí)質(zhì)可見(jiàn)壞死細(xì)胞,伴有炎細(xì)胞浸潤(rùn)及纖維組織增生。解剖胸腔,見(jiàn)兩肺彌漫性轉(zhuǎn)移結(jié)節(jié),部分小結(jié)節(jié)相互融合,HE可見(jiàn)腫瘤細(xì)胞侵犯支氣管及肺泡;2)在放療過(guò)程中,IMRT組有2只腫瘤模型兔死亡,一只動(dòng)物因麻醉過(guò)量致死,一只動(dòng)物由于腫瘤破潰至皮膚給予安樂(lè)死。三組之間的感興趣區(qū)(毗鄰骨骼的腫瘤組織)在DWI圖和ADC圖均表現(xiàn)出顯著的不同。對(duì)照組在DWI圖呈高信號(hào);在ADC圖呈明顯低信號(hào)。IMRT組在DWI圖呈欠均勻低信號(hào);在ADC圖呈高信號(hào)。VMAT組在DWI圖呈低信號(hào);在ADC圖呈高信號(hào)。3D-PDA觀察:三組之間的VI、FI及VFI均表現(xiàn)出顯著的不同,IMRT組和VMAT組明顯低于對(duì)照組。組織學(xué)結(jié)果,對(duì)照組:HE可見(jiàn)腫瘤細(xì)胞侵犯橫紋肌,正常的細(xì)胞結(jié)構(gòu)受到損害。IMRT組:HE可見(jiàn)腫瘤實(shí)質(zhì)及腫瘤邊界組織大片的壞死細(xì)胞,伴有炎細(xì)胞浸潤(rùn)及纖維組織增生。VMAT組在腫瘤毗鄰骨骼的區(qū)域可見(jiàn)一壞死帶形成,鏡下見(jiàn)細(xì)胞壞死明顯,纖維組織增生,周圍有炎細(xì)胞浸潤(rùn)。放療后,IMRT組和VMAT組的增殖活性降低、血管密度降低、凋亡增加;3)對(duì)照組、3Gy組和4Gy組的動(dòng)物在放療期間和放療后,局部皮膚未見(jiàn)異常。5Gy組有8只動(dòng)物在放療期間,局部皮膚出現(xiàn)了輕度紅斑和干燥性脫屑。對(duì)照組、3Gy組和4Gy組在鏡下可見(jiàn)正常的皮膚組織,皮膚表皮各層結(jié)構(gòu)完整。5Gy組可見(jiàn)表皮有大量的角化物質(zhì),上皮下有炎細(xì)胞浸潤(rùn)。對(duì)照組、3Gy組和4Gy組在鏡下可見(jiàn)骨細(xì)胞形態(tài)正常。5Gy組在鏡下可見(jiàn)骨細(xì)胞排列松散,細(xì)胞表現(xiàn)出明顯的萎縮。透射電鏡結(jié)果顯示,對(duì)照組、3Gy組和4Gy組的骨細(xì)胞形態(tài)正常。5Gy組可見(jiàn)粗面內(nèi)質(zhì)網(wǎng)擴(kuò)張,呈囊泡狀樣改變。FISH:EGF和PDGF-B的mRNA結(jié)果:對(duì)照組與3Gy組、4Gy組、5Gy組比較,其差異具有統(tǒng)計(jì)學(xué)意義(P0.05)。實(shí)時(shí)熒光定量PCR:VEGF mRNA結(jié)果:對(duì)照組與3Gy組、4Gy組比較,其差異具有統(tǒng)計(jì)學(xué)意義(P0.05),但與5Gy組比較未見(jiàn)明顯差異(P0.05)。bFGF mRNA結(jié)果:對(duì)照組與3Gy組、4Gy組比較其差異具有統(tǒng)計(jì)學(xué)意義(P0.05),但與5Gy組比較未見(jiàn)明顯差異(P0.05)。結(jié)論:1)通過(guò)超聲引導(dǎo)注射腫瘤組織懸液,成瘤率高,腫瘤生長(zhǎng)范圍較局限。影像學(xué)和組織學(xué)結(jié)果提示:后期的干預(yù)研究應(yīng)在種植腫瘤后的第14天左右進(jìn)行,以降低腫瘤內(nèi)部液化壞死對(duì)實(shí)驗(yàn)結(jié)果的影響;2)應(yīng)用VMAT-SIB技術(shù)在腫瘤模型上實(shí)施新輔助放療具有一定的可行性。MRDWI、3D-PDA、組織學(xué)證實(shí),在腫瘤毗鄰骨骼的區(qū)域制作的壞死帶,能夠有效的定義為外科邊界;3)在腫瘤模型上實(shí)施大劑量分割放療,結(jié)果提示VMAT-SIB 3Gy組和VMAT-SIB4Gy組的動(dòng)物能夠耐受早期的局部毒性反應(yīng),是一個(gè)相對(duì)較安全的劑量分割方案。
[Abstract]:Objective: 1) the tumor model of VX2 limb soft tissue in rabbits was established by ultrasonic guidance to lay the foundation for the later intervention study and imaging evaluation; 2) to implement new adjuvant radiotherapy on the tumor model, and to improve the radiation dose in the region adjacent to the adjacent bone with volume arc intensity modulated radiotherapy synchronous push (VMAT-SIB) technology, and to produce radioactivity damage locally. A necrotic band was defined as the surgical boundary, the feasibility and effectiveness of making the surgical boundary was evaluated. 3) in the tumor model, the surgical boundary was made by large fractionation radiotherapy, and the safety was evaluated. Method: 30 male New Zealand rabbits were selected to be randomly divided into 6 control groups (0.5ml under ultrasound guidance), and 24 in the model group. Ultrasound guided injection of the tumor tissue suspension 0.5ml. The two groups were treated with magnetic resonance diffusion imaging (MRDWI) and three-dimensional ultrasound to observe the tumor morphology, signal characteristics and volume changes. The control group died of animal observation after the collection of images. The model group was executed at fourteenth days, 21 days, 28 days and 6 animals were killed at random to observe histological changes. The remaining 6 animals were not killed, and the survival time of the tumor was observed; 2) 30 rabbit models were selected and randomly divided into the control group: 10; the intensity modulated radiotherapy (IMRT) group: 10; the VMAT-SIB group: 10. The three groups were collected for one week after radiotherapy: MRDWI, and three-dimensional energy Doppler ultrasound angiography (3D-PDA). Then, the animals were executed and histological changes were observed. And using immunohistochemistry to examine the proliferation, apoptosis, vascular density change of tumor tissue; 3) selected 40 tumor model rabbits, randomly divided into control group: 10 rats, group VMAT-SIB3Gy, 10; group VMAT-SIB4Gy, 10; group VMAT-SIB5Gy: 10. After radiotherapy, the general condition of skin was observed by CTCAE classification. HE staining was used to observe the skin and bone tissue. Morphological changes. The ultrastructural changes of the bone cells were observed by transmission electron microscopy. The expression of PDGF-B and EGF in skin tissue was measured by fluorescence in situ hybridization (FISH). The expression of VEGF and bFGF in skin tissue was measured by real-time fluorescence quantitative PCR. Results: 1) three dimensional ultrasound and MRDWI confirmed that the growth rate of 24 experimental animals was 100%, 24 The tumor model rabbits were all alive. The results of three-dimensional ultrasound showed no abnormal change at the injection site. The tumor volume in the model group increased gradually with the increase of time. Compared with the control group, the difference was statistically significant (P0.05).MRDWI showed that there was no obvious abnormal signal in the control group. The model group showed tumor image and tumor on the left hind limb. Tissue showed high signal on DWI map, low signal on ADC map. Histological results, control group: normal rhabdomyoma and bronchioloalveolar tissue were seen in HE. Model group: fourteenth days of extraction, HE visible growth of tumor cells were irregular and dense arrangement, invasion of rhabdomyoma. Twenty-first days, HE visible tumor area and flaky necrotic area boundary was unclear, tumor birth The cells in the long area were denser. After twenty-eighth days, the nuclei of the tumor were recovered and the nuclei were broken. The tumor cells were found on the edge of the tumor on the sixtieth day, and the tumor cells were still found on the edge of the tumor. The tumor was visible with necrotic cells, with inflammatory cells infiltration and fibrous tissue proliferation. The thoracic cavity was dissected, two pulmonary diffuse nodules were seen, and some small nodules fused, HE It can be seen that tumor cells invade bronchi and alveoli; 2) during the course of radiotherapy, 2 tumor model rabbits in group IMRT died, one animal died of overdose of anesthesia, and one animal broke into the skin for euthanasia due to the collapse of the tumor to the skin. The region of interest between the three groups (adjacent to the bone tumor group) showed significant differences between the DWI map and the ADC map. The group in the DWI map showed high signal, the ADC graph showed the low signal.IMRT group in the DWI diagram and the low signal in the DWI diagram; the high signal group in the ADC diagram showed the low signal in the DWI diagram; the VI, FI and VFI were significantly different between the three groups, and the group and the group were obviously lower than the control group. Histology results, control group: control group: It can be seen that the tumor cells infringe the rhabdomyosus muscle, and the normal cell structure is damaged in the.IMRT group: HE can be seen in the tumor parenchyma and the necrotic cells of the tumor boundary tissue, with the infiltration of inflammatory cells and the proliferation of fibrous tissue in the.VMAT group, a necrotic zone is visible in the area adjacent to the adjacent bone, and the necrosis of the cells, the proliferation of fibrous tissue, and the surrounding area are observed under the microscope. After radiotherapy, the proliferation activity of IMRT group and VMAT group decreased, blood vessel density decreased, apoptosis increased; 3) control group, 8 animals in group 3Gy and 4Gy group had no abnormal.5Gy group during radiotherapy and radiotherapy, and the local skin appeared mild erythema and dryness desquamation during radiotherapy. The control group, 3Gy group and 4Gy were in the control group. The normal skin tissue was seen under the microscope, and the epidermis of all layers of the skin had a large number of keratinized substances and infiltration of inflammatory cells under the epithelium. In the control group, group 3Gy and group 4Gy showed that the bone cell morphology in the normal.5Gy group was visible under the microscope, and the cells were loosely arranged and the cells showed obvious atrophy. The transmission electron microscope showed that the transmission electron microscope showed that the cells were obviously atrophied under the microscope. In the control group, the 3Gy group and the 4Gy group, the normal.5Gy group showed the dilation of the rough endoplasmic reticulum and the mRNA results of the vesicular like change of.FISH:EGF and PDGF-B. The control group was statistically significant compared with the 3Gy group, 4Gy group and 5Gy group (P0.05). The real time fluorescence quantitative PCR:VEGF mRNA results were compared with those in the control group. Statistical significance (P0.05), but compared with the 5Gy group, there was no significant difference (P0.05).BFGF mRNA results: in the control group and the 3Gy group, the difference in the 4Gy group was statistically significant (P0.05), but there was no significant difference between the group and the 5Gy group (P0.05). Conclusion: 1) the tumor growth rate was high and the growth range of the tumor was limited by ultrasound guided injection of tumor tissue suspension. The results of image and histology suggest that the later intervention study should be carried out about fourteenth days after the tumor is planted to reduce the effect of internal liquefaction and necrosis of the tumor to the experimental results. 2) the application of VMAT-SIB technology to the neoadjuvant radiotherapy on the tumor model has a certain feasibility,.MRDWI, 3D-PDA, histologically confirmed, in the region adjacent to the bone. The necrotic zone made by the domain can be effectively defined as the surgical boundary; 3) the large dose fractionation radiotherapy on the tumor model indicates that the animals in the VMAT-SIB 3Gy group and the VMAT-SIB4Gy group can tolerate the early local toxicity, which is a relatively safe dose division scheme.
【學(xué)位授予單位】：新疆醫(yī)科大學(xué)
【學(xué)位級(jí)別】：博士
【學(xué)位授予年份】：2015
【分類號(hào)】：R738.6;R-332

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 潘海濤;楊述華;劉勇;葉樹(shù)楠;;可移植性鼠骨肉瘤腫瘤模型的建立[J];華中醫(yī)學(xué)雜志;2005年06期

2 孫培鳴;徐迎新;李榮;;體外三維腫瘤模型的研究進(jìn)展[J];解放軍醫(yī)學(xué)院學(xué)報(bào);2013年02期

3 金國(guó)祥;龔興國(guó);黃勤;費(fèi)儉;;表達(dá)β-半乳糖苷酶的gal B16腫瘤模型的建立及其在腫瘤DNA疫苗研究中的應(yīng)用[J];實(shí)驗(yàn)生物學(xué)報(bào);2004年05期

4 王希;林菁;;倉(cāng)鼠腫瘤模型的研究和應(yīng)用進(jìn)展[J];福建醫(yī)藥雜志;2010年02期

5 湯宇,崔雪梅,袁玫,盧世璧,黃靖香,朱克順;小鼠S180肉瘤腫瘤模型生長(zhǎng)規(guī)律及熱休克蛋白的表達(dá)[J];醫(yī)學(xué)研究生學(xué)報(bào);2004年05期

6 黃德健;張健;孫勝祿;孔銘;方志軍;王小寧;殷志琦;倪以成;;大鼠肝移植腫瘤模型的影像學(xué)研究[J];藥物生物技術(shù);2011年01期

7 王紅麗;陳苑;胡銀霞;許華亮;黃仕穩(wěn);單孔榮;莊曉玲;;皮膚光損傷腫瘤模型的建立[J];中國(guó)比較醫(yī)學(xué)雜志;2013年09期

8 魏強(qiáng);方亮;楊繼金;霍寧寧;呂虎;熊源長(zhǎng);江旭;李慧;;兔肝臟、肌肉、皮下VX_2腫瘤模型的建立和對(duì)比研究[J];介入放射學(xué)雜志;2013年11期

9 蘇靜;陳文直;王嫣;劉麗萍;龔曉波;王智彪;;兔VX_2肌肉腫瘤模型的建立及生物學(xué)特性[J];中國(guó)組織工程研究與臨床康復(fù);2008年11期

10 孟令新;李江濤;;白細(xì)胞介素12在裸鼠腫瘤模型早期檢測(cè)中的應(yīng)用[J];中華臨床醫(yī)師雜志(電子版);2011年05期

相關(guān)會(huì)議論文 前4條

1 褚朝順;苗毅;奚春華;平定;王杰;呂朋華;Yicheng Ni;Gay Marchal;;兔局限性腫瘤模型的建立[A];中華醫(yī)學(xué)會(huì)第10屆全國(guó)胰腺外科學(xué)術(shù)研討會(huì)論文匯編[C];2004年

2 陳晟;鄧鋼;牛煥章;何仕誠(chéng);方文;汪盛齊;馬占龍;郭金和;李國(guó)昭;滕皋軍;;兔VX2肝種植腫瘤模型制作的完善及綜合影像學(xué)評(píng)價(jià)[A];中華醫(yī)學(xué)會(huì)第十三屆全國(guó)放射學(xué)大會(huì)論文匯編（下冊(cè)）[C];2006年

3 范恩學(xué);孫海俠;朱桂彬;王悅增;;血管抑素在小鼠開(kāi)窗可視腫瘤模型中的應(yīng)用[A];“振興吉林老工業(yè)基地——科技工作者的歷史責(zé)任”吉林省第三屆科學(xué)技術(shù)學(xué)術(shù)年會(huì)論文集（下）[C];2004年

4 馬玉飛;于俊峰;;~(188)Re標(biāo)記的含RGD序列多肽在整合素α_vβ_3表達(dá)陽(yáng)性腫瘤模型中的評(píng)價(jià)[A];中華醫(yī)學(xué)會(huì)第九次全國(guó)核醫(yī)學(xué)學(xué)術(shù)會(huì)議論文摘要匯編[C];2011年

相關(guān)博士學(xué)位論文 前2條

1 王崇文;超聲引導(dǎo)下建立兔VX2肢體軟組織腫瘤模型及應(yīng)用VMAT-SIB技術(shù)制作外科邊界的實(shí)驗(yàn)研究[D];新疆醫(yī)科大學(xué);2015年

2 江豐;磁共振導(dǎo)航的高強(qiáng)度聚焦超聲消融鄰近山羊門靜脈的肝組織的安全性和有效性的實(shí)驗(yàn)研究及靠近大血管的VX2腫瘤模型的建立[D];重慶醫(yī)科大學(xué);2010年

相關(guān)碩士學(xué)位論文 前7條

1 時(shí)廣力;術(shù)前SIB-VMAT應(yīng)用于兔肢體軟組織腫瘤模型的可行性研究[D];新疆醫(yī)科大學(xué);2015年

2 蘇紅;小鼠移植腫瘤模型的建立及黃楊類化合物的體外篩選[D];昆明理工大學(xué);2013年

3 孫俠;己烯雌酚致腫瘤模型研究[D];揚(yáng)州大學(xué);2005年

4 蔣茂榮;腫瘤模型動(dòng)物的人內(nèi)皮抑素基因治療初步研究[D];揚(yáng)州大學(xué);2003年

5 童樹(shù)友;兔口腔Vx-2腫瘤模型建立的實(shí)驗(yàn)研究[D];安徽醫(yī)科大學(xué);2008年

6 石然;基于細(xì)胞3D打印技術(shù)的腫瘤模型構(gòu)建研究[D];杭州電子科技大學(xué);2015年

7 徐加菊;兔多器官VX2動(dòng)物模型建立的實(shí)驗(yàn)研究[D];泰山醫(yī)學(xué)院;2010年

，

本文編號(hào)：2064206